Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis

Veterinary Ophthalmology

Volumn 13, Issue 5, 2010, Pages 294-300

  Gilger, Brian C ^a   Wilkie, David A ^b   Clode, Allison B ^a   McMullen, Richard J ^a   Utter, Mary E ^c   Komaromy, Andras M ^c   Brooks, Dennis E ^d   Salmon, Jacklin H ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cyclosporine; Equine; Implant; Recurrent uveitis

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; FEMALE; HORSE; HORSE DISEASE; INFUSION PUMP; MALE; UVEITIS;

ANIMALS; CYCLOSPORINE; FEMALE; HORSE DISEASES; HORSES; IMMUNOSUPPRESSIVE AGENTS; INFUSION PUMPS, IMPLANTABLE; MALE; UVEITIS;

EQUIDAE;

EID: 77956295513     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2010.00807.x     Document Type: Article

References (28)

1. Gilger BC, Malok E, Cutter KV. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Veterinary Immunology and Immunopathology 1999, 71:17-28.
2. Deeg CA, Kaspers B, Gerhards H. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Investigative Ophthalmology and Visual Science 2001, 42:393-398.
3. Deeg CA, Ehrenhofer M, Thurau SR. Immunopathology of recurrent uveitis in spontaneously diseased horses. Experimental Eye Research 2002, 75:127-133.
4. Deeg CA, Thurau SR, Gerhards H. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. European Journal of Immunology 2002, 32:2598-2606.
5. Deeg CA, Amann B, Raith AJ. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Investigative Ophthalmology and Visual Science 2006, 47:652-656.
6. Deeg CA, Pompetzki D, Raith AJ. Identification and functional validation of novel autoantigens in equine uveitis. Molecular & Cellular Proteomics 2006, 5:1462-1470.
7. Deeg CA, Hauck SM, Amann B. Major retinal autoantigens remain stably expressed during all stages of spontaneous uveitis. Molecular Immunology 2007, 44:3291-3296.
8. Deeg CA. Ocular immunology in equine recurrent uveitis. Veterinary Ophthalmology 2008, 11(Suppl. 1):61-65.
9. Gilger BC, Salmon JH, Yi NY. Role of bacteria in the pathogenesis of recurrent uveitis in horses from the southeastern United States. American Journal of Veterinary Research 2008, 69:1329-1335.
10. Deeg CA, Hauck SM, Amann B. Equine recurrent uveitis - a spontaneous horse model of uveitis. Ophthalmic Research 2008, 40:151-153.
11. Kay J. Inhibitory effects of cyclosporin A on lymphocyte activation. Cyclosporine: Mode of Action and Clinical Application 1989, 1-23. Thomson A. In, ed, Kluwer Academic Publishers, Dordrecht
12. Gilger BC, Salmon JH, Wilkie DA. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Investigative Ophthalmology and Visual Science 2006, 47:2596-2605.
13. Dwyer A, Gilger BC. Equine recurrent uveitis. Equine Ophthalmology 2005, 42-62. Gilger BC, In, ed, Elsevier, Philadephia, PA
14. Dwyer AE, Crockett RS, Kalsow CM. Association of leptospiral seroreactivity and breed with uveitis and blindness in horses: 372 cases (1986-1993). Journal of the American Veterinary Medical Association 1995, 207:1327-1331.
15. Angelos J, Oppenheim Y, Rebhun W. Evaluation of breed as a risk factor for sarcoid and uveitis in horses. Animal Genetics 1988, 19:417-425.
16. Rebhun WC. Diagnosis and treatment of equine uveitis. Journal of the American Veterinary Medical Association 1979, 175:803-808.
17. Sillerud CL, Bey RF, Ball M. Serologic correlation of suspected Leptospira interrogans serovar pomona-induced uveitis in a group of horses. Journal of the American Veterinary Medical Association 1987, 191:1576-1578.
18. Dwyer A. Visual prognosis in horses with uveitis. 1998, 22-23. American Society of Veterinary Ophthalmology Annual Meeting, Chicago, IL
19. Yamamoto T, Hattori M, Yoshida T. Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell. Immunology 2007, 121:383-391.
20. Kawai M, Kitade H, Mathieu C. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005, 79:1073-1077.
21. Terrada C, Fisson S, De Kozak Y. Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. Journal of Immunology 2006, 176:7171-7179.
22. Yeh S, Li Z, Forooghian F. CD4 + Foxp3 + T-regulatory cells in noninfectious uveitis. Archives of Ophthalmology 2009, 127:407-413.
23. Noris M, Casiraghi F, Todeschini M. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. Journal of the American Society of Nephrology 2007, 18:1007-1018.
24. Abadja F, Videcoq C, Alamartine E. Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance. Transplantation Proceedings 2009, 41:3367-3370.
25. Liu X, Yang P, Lin X. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clinical Immunology 2009, 131:333-342.
26. Zhang C, Zhang J, Yang B. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008, 42:345-352.
27. Kopf H, de la Rosa GM, Howard OM. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3 + T regulatory cells. International Immunopharmacology 2007, 7:1819-1824.
28. Douglas LC, Yi NY, Davis JL. Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses. Journal of Veterinary Pharmacology and Therapeutics 2008, 31:511-516.